Inclusive of all taxes
Tranexamic Acid & Etamsylate Tablets is a specialized pharmaceutical formulation created specifically for the management of gynecologic disorders associated with bleeding. This combined tablet harnesses the antifibrinolytic action of Tranexamic Acid with the capillary stabilizing properties of Etamsylate, effectively reducing excessive menstrual and other gynecological hemorrhages. Manufactured under stringent GMP-compliant, WHO-approved facilities by IndiGlobal Exports, these tablets maintain consistent dosage strength and ensure therapeutic efficacy. The formulation is optimized for both hospital and retail pharmacy usage, packaged in export-grade blister or strip packs to preserve drug stability during transport and storage, thereby catering perfectly to international markets requiring high standards of quality and regulatory compliance. Suitable for healthcare providers and pharmaceutical distributors focusing on women’s health, this product provides a reliable, targeted solution to manage gynecological bleeding disorders with enhanced safety and proven results.
Key Features
| Features | Description |
|---|---|
| Therapeutic Application | Management of gynecological bleeding associated with menstruation and other conditions |
| Active Ingredients | Tranexamic Acid and Etamsylate combined in a single tablet for synergistic hemostatic effect |
| Manufacturing Standards | Produced in WHO-GMP certified facilities ensuring high purity and quality |
| Packaging | Export-grade blister or strip packs designed for international distribution |
| Dosage Form | Tablet ensuring precise dosage and ease of administration |
| Regulatory Compliance | Compliant with IP/USP pharmacopoeial standards for export markets |
| Shelf Life | As per regulatory standards, ensuring stability over extended storage |
| Target Market | Hospitals, clinics, and pharmaceutical distributors specializing in gynecology |
| Manufacturer | IndiGlobal Exports, a trusted name in export-quality pharmaceuticals |
| Attributes | Description |
|---|---|
| Category | Gynecology |
| Formulation | Tablet |
| Packaging Type | Blister or strip packs |
| Active Pharmaceutical Ingredients | Tranexamic Acid, Etamsylate |
| Shelf Life | In accordance with international regulatory standards |
| Manufacturing Facility | GMP compliant, WHO-approved |
| Compliance Standards | IP/USP pharmacopoeial quality benchmarks |
| Intended Use | Control and management of gynecological hemorrhages |
| Export Quality | Yes, suitable for global pharmaceutical markets |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The combination provides a dual mechanism: Tranexamic Acid inhibits fibrinolysis reducing blood clot breakdown, while Etamsylate strengthens capillary walls and reduces capillary bleeding, offering enhanced control over gynecological hemorrhages.
Yes, the tablets are manufactured in WHO-GMP compliant facilities and meet IP/USP pharmacopoeial standards, making them fully compliant with international regulatory requirements for export.
The tablets are packed in high-quality export-grade blister or strip packs that protect against moisture, light, and contamination, ensuring maintained potency and shelf life throughout transit.
Yes, Tranexamic Acid & Etamsylate Tablets are appropriate for both hospital prescriptions and distribution through retail pharmacies specializing in gynecologic medications.
It adheres to WHO-GMP manufacturing guidelines and complies with recognized IP/USP pharmacopoeial standards, ensuring quality and safety for international healthcare markets.
Brand: indiglobal exports
Country Of Origin: India
Tranexamic Acid & Etamsylate Tablets is a pharmaceutical product indicated for gynecology treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Tranexamic Acid & Etamsylate Tablets is developed for the effective management of gynecology conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with gynecology indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
